Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 11.66
-0.14 (-1.19%)
Jul 31, 2026, 5:30 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 242.6 million as of July 31, 2026. Its market cap has increased by 74.37% in one year.
Market Cap
242.60M
Enterprise Value
251.24M
Revenue
17.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.66
ChartMarket Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 242.60M, a decrease of -21.50%. That is a compound annual growth rate of -1.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 242.60M | -49.04% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.61B |
| Idorsia | 1.56B |
| Basilea Pharmaceutica AG | 643.35M |
| Santhera Pharmaceuticals Holding AG | 212.07M |
| BioVersys AG | 155.73M |
| Molecular Partners AG | 124.91M |
| Xlife Sciences AG | 96.08M |
| MindMaze Therapeutics Holding | 30.40M |